Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer

Rome, ITALY, June 13, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully integrated bioinformatics and commercial molecular diagnostic company, today announced that...
February 19, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®

PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology, an on-line, peer-reviewed, open access...
February 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

PARSIPPANY, NJ, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21st BIO CEO & Investor Conference being held in New...
January 29, 2019 16:20 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
January 24, 2019 16:35 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
January 24, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
September 17, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups

Interpace Employees Participate in Local Events in Support of Lustgarten Foundation for Pancreatic Cancer Research, Thyroid, Head and Neck Cancer Foundation, and Pancreatic Cancer Action Network ...
August 15, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy

Several Former Rosetta Employees and Select Customers Also Join Interpace Parsippany, NJ, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the...